| Strong contract wins build commercial momentum | 14-Nov-2025 | 07:00 | RNS |
| New contract with top five pharma company | 04-Nov-2025 | 07:00 | RNS |
| Posting of Annual Report and Notice of AGM | 03-Nov-2025 | 07:00 | RNS |
| Full Year Results for the 12mths to 30 June 2025 | 14-Oct-2025 | 07:00 | RNS |
| New contract with top 10 pharma | 13-Oct-2025 | 07:00 | RNS |
| Notice of Results, Analyst & Investor Presentation | 10-Oct-2025 | 07:00 | RNS |
| Major top 3 global pharma contract win | 08-Oct-2025 | 07:00 | RNS |
| Notification of dealings by a director/PDMR | 09-Sep-2025 | 07:00 | RNS |
| Therapeutic development agreement with Invizius | 02-Sep-2025 | 07:00 | RNS |
| Block Listing Interim Review | 28-Aug-2025 | 07:00 | RNS |
| Biomarker Discovery Service Launch | 27-Aug-2025 | 07:00 | RNS |
| Update on licensing and development progress | 22-Aug-2025 | 07:00 | RNS |
| Exercise of warrants | 19-Aug-2025 | 07:00 | RNS |
| Holding(s) in Company | 18-Aug-2025 | 15:44 | RNS |
| Contract extension with global pharma partner | 18-Aug-2025 | 07:00 | RNS |
| Currency | UK Pounds |
| Share Price | 0.90p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 1.30p |
| 52 Week Low | 0.25p |
| Volume | 2,084,858 |
| Shares Issued | 2,696.98m |
| Market Cap | £24.27m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 15:54 | 57,741 @ 0.87p |
| 15:02 | 10,514 @ 0.89p |
| 13:08 | 78,300 @ 0.89p |
| 12:52 | 12,976 @ 0.89p |
| 10:59 | 14,000 @ 0.89p |
| CEO | Arron Tolley |
| CFO | Andrew Rapson |
You are here: research